Russia claims that its anti-Covid vaccine Sputnik Light is 70 percent effective against the delta variant of Corona in the first three months after injection. Russia's sovereign wealth fund said on Wednesday that the single-dose vaccine has the potential to become Russia's main vaccine.
The Russian Direct Investment Fund (RDIF) said that the Gamelia Center has submitted an article to the MedRXIV Preprint Server for Health Sciences on the effectiveness of the Sputnik Light vaccine against the delta variant of Corona.
The official statement said that the analysis done on the anti-Covid vaccine Sputnik Light was based on data received from 28 thousand participants. All of them were given a single dose of Sputnik Light Vaccine. In the study, they were compared with a group of 56 lakh people who did not get the vaccine.
The data used in the study was collected in Moscow this year. The study found that this vaccine is more than 75 percent effective in people under 60 years of age. The anti-Covid Sputnik Light Vaccine significantly prevents serious illness and hospitalization, the statement said. Let us tell you that the single-dose Sputnik Light vaccine has been approved in more than 15 countries.
Not only this, the process of its registration is going on in 30 other countries. The delta variant of the corona is the most dangerous and contagious. Denis Logunov, deputy director of the Gamelia Center, said the data analysis presented in the article shows Sputnik Light remains highly effective for months after vaccination.
At the same time, RDIF Chief Executive Officer Kirill Dmitriev said that the effective results of the Sputnik Light vaccine against the delta variant of Corona are much better than the two-shot vaccines. It is known that the Drugs Controller General of India (DCGI) has given permission for the third phase trial of Russia's Sputnik Light Vaccine in India.